The 2023 European Society of Cardiology (ESC) guidelines for acute and chronic heart failure (HF) include upgraded recommendations for intravenous (IV) iron supplementation, including Ferinject ® ...

There have been numerous improvements in the treatment of cardiovascular disease since the European Society of Cardiology (ESC) first met in 1950, but unmet medical need remains and the science ...

Windtree Therapeutics, Inc. announced progress in its research on istaroxime and a selective SERCA2a activator, demonstrating a reduction in arrhythmias in an animal study, which will be presented at ...

Toronto, Ontario--(Newsfile Corp. - February 10, 2026) - Cardiol Therapeutics Inc. (CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of ...

Smartphone stethoscopes, voice-detected heart failure, training using physical and virtual hearts, as well as early detection of cardiovascular disease using blood spots are among the innovations ...

Windtree Therapeutics, Inc. announced that data from the SEISMiC Extension Phase 2b study on istaroxime will be presented at the European Society of Cardiology Heart Failure 2025 Conference in ...

Madrid, Spain – 29 August 2025: Updated ESC/EACTS Guidelines, being published today at ESC Congress 2025, aim to improve the way that patients with valvular heart disease are diagnosed and treated, ...

Kasr Al Ainy receives ESC Heart Failure Association accreditation, joining just 14 global centres recognised for excellence ...

New data from the SHIFT trial, presented at the European Society of Cardiology (ESC) 2011 Congress, show that in addition to the main result of a reduction in death/hospitalization, patients on the ...